Charlotte’s research aims are to provide breast cancer patients with the best chance of cure with least side effects by personalising radiation techniques based on risk of recurrence.
She is Chief Investigator of multiple clinical trials with linked translational research. She is also the Lead for CRUK RadNet Cambridge.
